PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16051698-7	2005	This was sensitive to inhibition by the beta(2)-adrenoceptor antagonists propranolol, timolol, and ICI 118551.	Propranolol	73-84	adrenergic receptor, beta 2	Mus musculus	40-60	
14744619-4	2004	In mouse ileum, stereoselectivity of propranolol and tertatolol was observed under beta(1)-/beta(2)-adrenoceptor blockade.	Propranolol	37-48	adrenergic receptor, beta 2	Mus musculus	92-112	
10758054-8	2000	Propranolol administration reduced baseline +dP/dt(max) to nontransgenic levels in all beta(2)AR transgenics except the 350-fold overexpressors, indicating that spontaneous activation of beta(2)AR was present at this level of expression.	Propranolol	0-11	adrenergic receptor, beta 2	Mus musculus	87-96	
13679574-3	2003	Here we show that beta2AR ligands like ICI118551 and propranolol, which are inverse agonists for Gs-stimulated adenylyl cyclase, induce partial agonist responses for the mitogen-activated protein kinases extracellular signal-regulated kinase (ERK) 1/2 thus behaving as dual efficacy ligands.	Propranolol	53-64	adrenergic receptor, beta 2	Mus musculus	18-25	
10758054-8	2000	Propranolol administration reduced baseline +dP/dt(max) to nontransgenic levels in all beta(2)AR transgenics except the 350-fold overexpressors, indicating that spontaneous activation of beta(2)AR was present at this level of expression.	Propranolol	0-11	adrenergic receptor, beta 2	Mus musculus	187-196	
8734469-6	1996	The responses to prenalterol and salbutamol were inhibited by propranolol at relatively low concentrations, suggesting their effects were mediated by beta 1AR and beta 2AR, respectively.	Propranolol	62-73	adrenergic receptor, beta 2	Mus musculus	163-171	
32450072-1	2020	Propranolol is a ss-adrenoreceptor type 2 (ADRB2) blocker that regulates heart muscle contractions, smooth muscle relaxation and glycogenolysis.	Propranolol	0-11	adrenergic receptor, beta 2	Mus musculus	43-48	
1438344-7	1992	Additionally, propranolol, a nonspecific beta-blocker, partially reversed the suppression of platelet production by L-thyroxine, lending credence to the assertion that the direct, beta 2-adrenergic receptor-mediated stimulation of the erythroid cell line by thyroxine reported to exist in vitro may also be important in vivo.	Propranolol	14-25	adrenergic receptor, beta 2	Mus musculus	180-206	
2834198-6	1988	This response was fully blocked by the beta 2AR antagonist, propranolol.	Propranolol	60-71	adrenergic receptor, beta 2	Mus musculus	39-47	
32138352-3	2020	This study explores the modulation of beta1 and beta2 adrenergic receptors (ADRB1/ADRB2) by propranolol treatment on the peripheral and splenic immune dysfunction of cirrhotic mice.	Propranolol	92-103	adrenergic receptor, beta 2	Mus musculus	82-87	
32138352-10	2020	In conclusion, suppression of ADRB1 and ADRB2 expressions in spleen and splenic T lymphocytes by acute and chronic propranolol treatment ameliorate systemic and splenic immune dysfunction in cirrhosis.	Propranolol	115-126	adrenergic receptor, beta 2	Mus musculus	40-45	
30229289-6	2019	The effect of ISO was specifically dependent upon beta2-AR, since it was not seen in adrb2-/- CD8+ T-cells and was blocked by the beta-AR antagonist propranolol.	Propranolol	149-160	adrenergic receptor, beta 2	Mus musculus	50-58	
30229289-6	2019	The effect of ISO was specifically dependent upon beta2-AR, since it was not seen in adrb2-/- CD8+ T-cells and was blocked by the beta-AR antagonist propranolol.	Propranolol	149-160	adrenergic receptor, beta 2	Mus musculus	130-137	
25929826-5	2015	Propranolol treatment during PSD reversed these effects, indicating a major inhibitory role of beta-adrenergic receptors (beta-AR) on NK cells function.	Propranolol	0-11	adrenergic receptor, beta 2	Mus musculus	122-129	
25872592-0	2015	Propranolol represses infantile hemangioma cell growth through the beta2-adrenergic receptor in a HIF-1alpha-dependent manner.	Propranolol	0-11	adrenergic receptor, beta 2	Mus musculus	67-92	
25872592-5	2015	In vitro analysis revealed that propranolol reduces the expression of HIF-1alpha in hemangioma cells in a dose- and time-dependent manner, mainly by acting on beta2-AR.	Propranolol	32-43	adrenergic receptor, beta 2	Mus musculus	159-167	
29611347-7	2018	Pretreatment with propranolol, a beta1- and beta2-adrenergic receptor (AR) antagonist, trended toward rescuing the inhibitory effects of NE in primary cell culture.	Propranolol	18-29	adrenergic receptor, beta 2	Mus musculus	44-69	
29611347-7	2018	Pretreatment with propranolol, a beta1- and beta2-adrenergic receptor (AR) antagonist, trended toward rescuing the inhibitory effects of NE in primary cell culture.	Propranolol	18-29	adrenergic receptor, beta 2	Mus musculus	71-73	
21177286-4	2011	Stimulation of beta(2)-AR by isoproterenol inhibited Col II mRNA and protein levels by ~50% beginning at 2 h, with both remaining suppressed over 24 h. This inhibition was blocked by propranolol and inhibitors of either MEK1 or PKA.	Propranolol	183-194	adrenergic receptor, beta 2	Mus musculus	15-25